Charles Q. Morris
CIK: 0001489966
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Morris Charles Q
Morris Charles Q (SEC CIK 0001489966) files insider reports with the SEC as Chief Medical Officer of Prelude Therapeutics Inc (PRLD) and Chief Medical Officer of LAVA Therapeutics NV (LVTX).
Signal8 holds 4 ownership filings by Morris Charles Q (2 Form 3, 2 Form 4), filed between Jan 2, 2025 and May 4, 2026. Those filings report 2 transactions, from Feb 13, 2025 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Morris Charles Q's filings is in WILMINGTON, DE.
Recent filings by Morris Charles Q
Other insiders filing for Prelude Therapeutics Inc (PRLD)
- BAKER BROS. ADVISORS LP, Director
- Dorton Katina, Director
- Babler Martin, Director
- Bonita David P, Director
- Sandor Victor, Director
- FRIEDMAN PAUL A, Director